- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05447130
Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome
September 8, 2022 updated by: Hosny Ahmed Zein, Minia University
Corneal Endothelial Evaluation After Phacoemulsification in Eyes With Pseudoexfoliation Syndrome
To study corneal endothelial cells changes after phacoemulsification in patients with senile cataract and pseudoexfoliation syndrome (PEX) compared with control patients with senile cataract using specular microscope.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In a prospective interventional case-control study, 20 eyes with cataract and PEX and 20 control eyes with cataract without PXE were subjected to phacoemulsification and posterior chamber foldable intraocular lens implantation in Minia University Hospital and Genaidy Eye Center between March 2019 and December 2020.
Specular microscopy was done preoperatively, 3 and 6 months postoperatively.
Endothelium cell density (ECD), coefficient variation (CV), hexagonality, pleomorphism and corneal thickness were evaluated and compares between PXE and control eyes.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minia
-
Minya, Minia, Egypt, 61111
- Minia University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- senile cataract age more than 55 years
Exclusion Criteria:
- PEX with glaucoma, eyes with cornea guttata or any corneal dystrophy, zonular dehiscence, very dense nuclear cataract (cataracta nigra) history of previous ocular surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Corneal Endothelial Evaluation after Phacoemulsification in Eyes with Pseudoexfoliation Syndrome
|
phacoemulsification with corneal endothelial evaluation by specular microscopy
|
Experimental: Corneal Endothelial Evaluation after Phacoemulsification in Eyes without Pseudoexfoliation
|
phacoemulsification with corneal endothelial evaluation by specular microscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
corneal endothelial cell loss
Time Frame: 6 months
|
corneal endothelial cell loss
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
December 20, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
July 3, 2022
First Submitted That Met QC Criteria
July 3, 2022
First Posted (Actual)
July 7, 2022
Study Record Updates
Last Update Posted (Actual)
September 13, 2022
Last Update Submitted That Met QC Criteria
September 8, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEX2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Endothelial Cell Loss
-
Assiut UniversityNot yet recruitingEndothelial Cell Loss, Corneal
-
Asociación para Evitar la Ceguera en MéxicoEmmecellRecruiting
-
Prim. Prof. Dr. Oliver Findl, MBACompletedEndothelial Cell Loss, Corneal
-
Centre Hospitalier Régional Metz-ThionvilleCompletedCataract | Endothelial Cell Loss, Corneal | PhacoemulsificationFrance
-
Paracelsus Medical UniversityCompletedGlaucoma | Endothelial Cell Loss, CornealAustria
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingCorneal Endothelial Cell Loss | Corneal Transplant FailureSpain, Germany, Netherlands, Belgium, Italy, United Kingdom
-
Nidek Co. LTD.CompletedCorneal Endothelial Cell LossUnited States
-
Topcon Medical Systems, Inc.CompletedCorneal Endothelial Cell LossUnited States
-
Assiut UniversityNot yet recruitingCorneal Endothelial Cell Loss
-
Topcon Medical Systems, Inc.CompletedCorneal Endothelial Cell LossUnited States
Clinical Trials on phacoemulsification
-
University Tunis El ManarCompletedEffect of Cataract Surgery on Corneal Endothelium; About 2 TechniquesTunisia
-
State University of New York at BuffaloActive, not recruitingGlaucomaUnited States
-
University of California, San FranciscoTerminated
-
Iladevi Cataract and IOL Research CenterCompleted
-
University of Turin, ItalyCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCompleted
-
Democritus University of ThraceCompleted
-
Ophthalmic Consultants, Corneal and Refractive...Unknown
-
Iladevi Cataract and IOL Research CenterCompletedPosterior Capsule OpacificationIndia